iTeos Therapeutics, Inc. (ITOS)
NASDAQ: ITOS · Real-Time Price · USD
8.97
+0.16 (1.82%)
Nov 4, 2024, 4:00 PM EST - Market closed
iTeos Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 4, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 328 | 392 | 695 | 1,642 | 1,185 | - | |
| Market Cap Growth | 16.79% | -43.60% | -57.70% | 38.57% | - | - | |
| Enterprise Value | -238 | -201 | -53 | 745 | 845 | - | |
| Last Close Price | 8.97 | 10.95 | 19.53 | 46.56 | 33.82 | - | |
| PE Ratio | - | -3.48 | 7.63 | 8.20 | -11.74 | - | |
| PS Ratio | 9.43 | 31.11 | 2.60 | 4.76 | - | - | |
| PB Ratio | 0.49 | 0.68 | 1.05 | 2.97 | 3.67 | - | |
| P/FCF Ratio | -4.71 | -3.67 | -6.20 | 3.21 | -46.42 | - | |
| P/OCF Ratio | -4.85 | -3.78 | -6.25 | 3.20 | -47.08 | - | |
| EV/Sales Ratio | 3.13 | -15.98 | -0.20 | 2.16 | - | - | |
| EV/EBITDA Ratio | -0.79 | 1.37 | -0.41 | 3.04 | -19.03 | - | |
| EV/EBIT Ratio | -0.78 | 1.36 | -0.42 | 3.04 | -18.80 | - | |
| EV/FCF Ratio | -0.93 | 1.89 | 0.47 | 1.46 | -33.10 | - | |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | - | - | |
| Debt / EBITDA Ratio | - | - | 0.04 | 0.02 | - | - | |
| Debt / FCF Ratio | -0.05 | -0.06 | -0.04 | 0.01 | - | - | |
| Asset Turnover | 0.05 | 0.02 | 0.33 | 0.56 | - | - | |
| Quick Ratio | 17.70 | 13.46 | 14.66 | 2.83 | 22.45 | 1.91 | |
| Current Ratio | 18.08 | 13.76 | 14.96 | 2.88 | 22.64 | 1.98 | |
| Return on Equity (ROE) | -16.80% | -18.19% | 15.89% | 48.98% | -22.45% | -146.18% | |
| Return on Assets (ROA) | -12.05% | -12.97% | 9.72% | 24.90% | -14.97% | -58.61% | |
| Return on Capital (ROIC) | -13.51% | -14.77% | 13.00% | 34.73% | -16.58% | -110.91% | |
| Earnings Yield | -33.01% | -28.75% | 13.91% | 13.06% | -3.21% | - | |
| FCF Yield | -35.87% | -27.24% | -16.14% | 31.17% | -2.15% | - | |
| Buyback Yield / Dilution | -3.12% | 5.30% | 0.02% | -150.49% | -7336.29% | -9.20% | |
| Total Shareholder Return | -3.12% | 5.30% | 0.02% | -150.49% | -7336.29% | -9.20% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.